Wei Huang

Wei Huang

Auto-generated profile, based on publicly available information

Wei Huang

School of Pharmaceutical Sciences, Jilin University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MLMiao Liu
Miao Liu
JLJing Lu
Jing Lu
YCYujuan Chen
Yujuan Chen
DZDongmei Zhang
Dongmei Zhang
WHWei Huang
Wei Huang
JWJian Wang
Jian Wang
The herbal pairing of Huangqi and Dangshen (HD) is traditional Chinese herbal medicine and has been widely used in China, especially to treat myasthenia gravis (MG). However, the mechanism of HD on MG is unclear. Aim of the Study. This study aims to investigate HD’s possible role in MG treatment. Materials and Methods. The TCMSP database was used to identify the active chemicals and their targets. The GeneCards, DisGeNET, and OMIM databases were used to search for MG‐related targets. The STRING database was employed in order to identify the common PPI network targets. We next utilised Cytoscape 3.8.2 for target identification and the DAVID database for gene ontology (GO) function analysis as well as Encyclopaedia of Genomes (KEGG) pathway enrichment analysis on the selected targets. The AutoDock Vina software was used to test the affinity of essential components with the hub gene before concluding that the primary targets were corrected through molecular docking. Results. 41 active compounds were screened from HD, and the number of putative‐identified target genes screened from HD was 112. There were 21 target genes that overlapped with the targets of MG, which were postulated to be potential treatment targets. Through further analysis, the results showed that the active compounds from HD (such as 7‐methoxy‐2‐methylisoflavone, quercetin, luteolin, Kaempferol, and isorhamnetin) may achieve the purpose of treating MG by acting on some core targets and related pathways (such as EGFR, FOS, ESR2, MYC, ESR1, CASP3, and IL‐6). Molecular docking findings demonstrated that these active molecules have a near‐perfect ability to attach to the primary targets. Conclusion. Through network pharmacology, the findings in this study provide light on the coordinated action of several HD formula components, targets, and pathways. It provided a theoretical basis for further study of HD pharmacological action.

16 February 2020 in Cancers
Verified
Journal Article
Open access
PDF file
DHDianshuai Huang
Dianshuai Huang
QFQingjie Fan
Qingjie Fan
ZLZhiyi Liu
Zhiyi Liu
SZShuqin Zhang
Shuqin Zhang
WHWei Huang
Wei Huang
FSFei Sun
Fei Sun
The precise role of Epidermal Growth Factor Receptor (EGFR) in Hepatocellular carcinoma (HCC) cells is unknown and EGFR inhibitors have not achieved positive clinical results. The rapid and drastic internalization of EGFR has been proved to successfully treat EGFR inhibitor-resistant patients in recent clinical trials. Here, the anti-tumor efficacy of a protein (rLZ-8) from Ganoderma lucidum was evaluated, it was demonstrated that rLZ-8 could bind to EGFR specifically, drastically enter into Hepatoma cells, abrogate endosomal recycling and induce HCC cell death. Surprisingly, we screened a monoclonal antibody which possesses competitive binding site with rLZ-8, it also trigger catastrophic EGFR internalization. This result suggests that it is necessary to investigate the interface of EGFR and rLZ-8 complex. An internalization related epitope (S222/K269) was identified on the dimerization arm of EGFR extracellular domain (ECD). These results suggest vulnerability of HCC cells to catastrophic EGFR internalization that can be targeted by a novel epitope and point to the possible exploitation in the design of anti-EGFR therapeutic biologics for HCC therapy.

3 September 2026 in Journal of Chemotherapy
Verified
Journal Article
Closed access
MLMeng Li
Meng Li
JWJiayu Wang
Jiayu Wang
SFShuai Fang
Shuai Fang
LDLu Dai
Lu Dai
XSXilin Sun
Xilin Sun
WHWei Huang
Wei Huang
Hepatocellular carcinoma is still a significant cause of cancer deaths worldwide [1]. For patients with advanced stages, systemic therapy is a key treatment approach. Multi-targeted TKIs, such as s...